T1	Participants 278 314	for the acute treatment of migraine.
T2	Participants 315 431	Eighty patients treated all migraine attacks for 6 months at home with a subcutaneous injection of sumatriptan 6 mg.
T3	Participants 799 892	1566 attacks were treated by the 80 patients and 69 patients completed 6 months of treatment.
T4	Participants 1762 1801	patients using the novel self-injector.
